Now on Pharmaceutical Processing
Using Strategic Flexibility to Succeed in Emerging Pharmaceutical... Comments

Subscribe to Pharmaceutical Processing
 








Digital Library




























Industry News
Amneal Receives FDA Approval for Tramadol/APAP Tablets February 08, 2010  Comments
Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study February 08, 2010  Comments
BD Announces Worldwide Voluntary Recall of BD Q-Syte(TM) Luer Access Devices and BD Nexiva Closed IV Catheter Systems February 08, 2010  Comments
Cell Therapeutics Plunges on Negative FDA Review February 08, 2010  Comments
FDA Issues Complete Response Letter Regarding Strativa Pharmaceutical's NDA for Zuplenz Oral Soluble Film February 08, 2010  Comments
FDA Warns of Brain Risks with Frequent Tysabri Use February 08, 2010  Comments
IntelGenx Receives FDA Complete Response Letter Regarding CPI-300 February 08, 2010  Comments
Is the US Swine Flu Epidemic Over? February 08, 2010  Comments
Maine Study Reveals: Even if you're careful, drugs can end up in water February 08, 2010  Comments
Multiple Sclerosis Experts Join Biogen Idec's Research and Development Team February 08, 2010  Comments
Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration February 08, 2010  Comments
Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP February 08, 2010  Comments
SOHM India Signs Marketing Agreement Adding 75 Branded Generic Pharmaceutical Products for Distribution Across India February 08, 2010  Comments
Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions February 08, 2010  Comments
USP-WHO Study: One-Third of Antimalarial Medicines Sampled in Three African Nations Found to be Substandard February 08, 2010  Comments
Alkermes Reports Third Quarter Loss, Smaller Than Expected February 05, 2010  Comments
AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy February 05, 2010  Comments
BioMarin to Acquire LEAD Therapeutics February 05, 2010  Comments
FDA Concerned Dissolvable Tobacco Appeals to Kids February 05, 2010  Comments
FDA Using Computer Program to Track Risky Imports February 05, 2010  Comments
Glaxo Savings Plan May Hit XenoPort Partnership February 05, 2010  Comments
Mylan Confirms First-to-File Patent Challenge Relating to Caduet February 05, 2010  Comments
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients February 05, 2010  Comments
Teva Announces Settlement in Principle Regarding Certain Drug Pricing Lawsuits February 05, 2010  Comments
Vermont Attorney General Wants Drug Makers to Disclose Free Samples February 05, 2010  Comments
Allergan Fourth Quarter Profit Grows 51% as Sales Climb February 04, 2010  Comments
Bristol-Myers-Squibb Employee in NY Charged with Trade Theft February 04, 2010  Comments
GlaxoSmithKline Fourth Quarter Profit up 66% February 04, 2010  Comments
Lux Biosciences, Inc Files for LUVENIQ Approval in US and Europe February 04, 2010  Comments
Paladin Granted Priority Review Status for Abstral(R) by Health Canada February 04, 2010  Comments
Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trials for Palomid 529 in Age-Related Macular Degeneration Patients February 04, 2010  Comments
Poniard Pharmaceuticals Laying Off Staff, Changing Leadership February 04, 2010  Comments
Questcor Appoints Jason Zielonka, M.D. Chief Medical Officer February 04, 2010  Comments
BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytren's Contracture February 03, 2010  Comments
Eli Lilly Veteran Joins Genzyme to Head Manufacturing and Corporate Operations February 03, 2010  Comments
Glaxo CEO: Time to Diversify, Help Poor Countries February 03, 2010  Comments
Keryx Biopharmaceuticals Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Patients with Refractory Metastatic Colorectal Cancer February 03, 2010  Comments
Labopharm Gets FDA Approval for Once-a-Day Oleptro February 03, 2010  Comments
Medicis Receives Approval for RESTYLANE and PERLANE With Lidocaine February 03, 2010  Comments
Pfizer Posts Big Jump in Fourth Quarter Sales, Profit February 03, 2010  Comments
Roche 2009 Profit Down 22 percent on Genentech Costs February 03, 2010  Comments
MannKind Loss Narrows on Lower Costs February 02, 2010  Comments
Novo Nordisk Profits Largely Unchanged in the Fourth Quarter February 02, 2010  Comments
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial February 02, 2010  Comments
Protalix Announces NDA Submission Update for taliglucerase alfa for the Treatment of Gaucher Disease February 02, 2010  Comments
Study: Pharmaceutical New Product Planning Can Save Pharma/Biopharma Companies Millions February 02, 2010  Comments
Utah Aims to Curtail Prescription Drug Abuse February 02, 2010  Comments
Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer February 01, 2010  Comments
Boston Scientific to Pay Johnson & Johnson $1.73B in settlement February 01, 2010  Comments
Cephalon Acquires Swiss Drugmaker Mepha AG February 01, 2010  Comments
FDA Announces Safety Risk Associated with HIV Drug February 01, 2010  Comments
FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures February 01, 2010  Comments
GSK's TYKERB Receives Accelerated Approval for First-Line Combination Treatment of Metastatic Breast Cancer February 01, 2010  Comments
InterMune Gets March FDA Review for Lung Drug February 01, 2010  Comments
NeoStem's Suzhou Erye Pharmaceutical Subsidiary Receives Approval for First Two Manufacturing Lines in its New Facility February 01, 2010  Comments
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R) February 01, 2010  Comments
VYVANSE® ADHD Treatment Option Now Available in Canada February 01, 2010  Comments
Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S. February 01, 2010  Comments
YM BioSciences Completes Merger with Cytopia February 01, 2010  Comments

Industry News Archive

Latest Technologies

Tube Welding Power Supply Features A Full Size Color Touch Screen  
Welding power supply continue...

Segmented Turret Technology Helps Maximize Tablet Press Productivity  
Segmented turret technology continue...
 

More Products

Insight: Applications, Trends & Opinions
Using Strategic Flexibility to Succeed in Emerging Pharmaceutical Markets  Comments
The global recession and accompanying economic fallout of the past year have further emphasized the need for Western/multinational pharmaceutical companies (MNCs) to expand and diversify their sales efforts beyond the United States. The large and growing markets of China, India, Brazil, Mexico, Russia, Turkey and other countries offer rising incomes, a burgeoning middle class, improved IP protection, fast-developing infrastructure and increased spending on health care. continue...

Recent Features


Facility of the Year Award
Facility of the Year Awards 2008 ISPE, INTERPHEX and Pharmaceutical Processing have announced the 6 category winners in the 2009 Facility of The Year Award program. Click on a logo below to read more about each winning company’s facility

Read about the 2009 category winners:
Aseptic Orchid Centocor
Centocor Roche hameln
About  |   Past Winners  |   Submit Info

2008 Pharmaceutical Supplier Directory

The complete resource for the pharmaceutical manufacturing industry.

To add your company to the Directory click here.

View Pharmaceutical Processing's Directory of Manufacturers (PDF)

Search The Pharmaceutical Supplier Directory for suppliers and products for the pharmaceutical industry. To filter companies returned in the directory section of the search results screen, select a region from the list below:
Regions Served:
Biopharmaceutical Processing
Disposable Equipment, Disposable Components, Processing Equipment, ...
Clean Room Equipment & Supplies
Apparel / Clothing / Gloves, Cleaning Equip / Supplies, Facility Components, ...
Lab Instrumentation & QA / QC
Basic Laboratory Equipment, Apparatus, Supplies / Accessories, ...
Outsourcing
Packaging, Laboratory Services, Manufacturing Services, ...
Packaging
Material Handling, Packaging Materials, General Equipment, ...
Process Automation
Control Components / Applications, Computer Systems, Computers and Accessories, ...
Process Components, Supplies And Instrumentation
Actuators, Alarms, Analyzers, ...
Processing Equipment
Agglomeration Equipment, Bins & Bin Equipment, Blending / Granulating Equipment, ...
Raw Materials / Pharmaceutical Ingredients
Raw Materials / Pharmaceutical Ingredients, ...
Services
Testing / Studies, Custom Design / Build, Environmental Services, ...

Small Doses

Dear Santa...

by Mike Auerbach, Editor
Mike Auerbach, Editor Pharmaceutical Processing
Ok - yes - I'm too old to believe in Santa. But that won't stop me from putting together my own wish list.
You see, we are at interesting place in time. Not only is 2009 ending, but the first decade of the new century is also coming to a close. Is there a better time than now to look back at the first 10 years of the '00s, or the "aughts", or whatever clever term historians might use to put a label on this decade, and make a wish list for the next ten years?

In retrospect we should have known 10 years ago, we were in for some "interesting times" as the often-quoted Chinese proverb states, when the 2000 presidential election hung in the balance and was basically decided on the interpretation of what a "hanging chad" is.

So, without further ado, here is my wish list for the next ten years. Some "pie in the sky"- some more down to earth:

• Health and happiness for my family and friends.
Has to be the first one on my list - no apologies for this one.

• Cures and/or better treatments for all types of cancers.
I've seen way too much of this over the last ten years - can we finally eradicate this curse?

• Healthcare coverage that is affordable, accessible and understandable
Who could sift through a 2,000 page document and really understand it - much less vote on it?

• More investment and research into "real" diseases.
Sorry, hair loss and male enhancement products don't count as "real".

• Less stress about the economy, jobs, the environment, etc.
Is this possible? I sure hope so.

• Less hate, fewer wars and more tolerance.
Come on - can't we all get along?

That's it - that's all I'm asking for. I'm not sure if Santa will read this - but I think Santa follows me on Twitter.

More Small Doses






























Bioscience Technology Chromatography Techniques Drug Discovery & Development Laboratory Equipment Pharmaceutical Processing R&D Scientific Computing
Advantage Business Media © Copyright 2010 Advantage Business Media
Privacy Policy | Terms & Conditions | Advertise With Us